Caladrius Biosciences to Participate at Upcoming February Conferences
BASKING RIDGE, N.J., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select …